CervoMed Inc. (CRVO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.57M
Last updated: Nov 17, 2026 at 11:04 AM ET
CervoMed Inc. (CRVO) Competitors
The companies most similar to CervoMed are NextCure (NXTC), Cyclerion Therapeutics (CYCN) and CEL-SCI (CVM). By market cap, CervoMed ranks 7th of the 13 companies on this page; Mereo BioPharma Group PLC ADR (MREO) is the largest at $49.11M.
Peer Comparison
CRVO's revenue growth of -99.6% is below the peer median of -4.1%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| CervoMed (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| CEL-SCI Corp (CVM) | $22.51M | N/A | N/A | 0.0% | -109.0% | -62.7% | 0.00% |
| Transcode Therapeutics Inc (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| ProMIS Neurosciences Inc. (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mereo BioPharma Group PLC ADR (MREO) | $49.11M | N/A | 61.3x | 0.0% | -116.6% | 0.0% | 0.00% |
| Celularity Inc (CELU) | $20.45M | N/A | 1.0x | -245.7% | N/A | -5.3% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Edesa Biotech Inc (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Peer median | $24.36M | N/A | 2.0x | 0.0% | -264.6% | -4.1% | 0.00% |
Similar Companies
These are the 12 companies most similar to CervoMed, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| CEL-SCI Corp (CVM) | CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. | CVM competitors |
| Transcode Therapeutics Inc (RNAZ) | TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic... | RNAZ competitors |
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
| ProMIS Neurosciences Inc. (PMN) | ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases... | PMN competitors |
| Mereo BioPharma Group PLC ADR (MREO) | Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases... | MREO competitors |
| Celularity Inc (CELU) | Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta. | CELU competitors |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| Edesa Biotech Inc (EDSA) | Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development... | EDSA competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
Frequently Asked Questions About CRVO
Who are CervoMed's main competitors?
The companies most similar to CervoMed include NextCure (NXTC), Cyclerion Therapeutics (CYCN), CEL-SCI (CVM), Transcode Therapeutics (RNAZ) and Biocardia (BCDA), listed from the closest match.
Who is CervoMed's biggest competitor?
Mereo BioPharma Group PLC ADR (MREO) is the largest of the similar companies at $49.11M; NextCure (NXTC) is the closest match by business profile, size, sector and industry.
How does CRVO stock compare with its competitors?
CRVO's net margin is 0.0% against a peer median of 0.0%.
Which of CervoMed's competitors pays a higher dividend?
CervoMed pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is CervoMed bigger than its competitors?
No. CervoMed is 7th by market cap among the 13 companies on this page; the largest is Mereo BioPharma Group PLC ADR (MREO) at $49.11M.
CRVO pages: Overview, Earnings, Forecast, Financials, Competitors